Clinical trial
Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
NCT04921943 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 18, 2021
- Completion date
- December 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
nontuberculous mycobacterial lung disease, nontuberculous mycobacterium infection